FEXOFENADINE HYDROCHLORIDE HIVES Drug Patent Profile
✉ Email this page to a colleague
When do Fexofenadine Hydrochloride Hives patents expire, and what generic alternatives are available?
Fexofenadine Hydrochloride Hives is a drug marketed by Dr Reddys Labs Ltd, Rising, Sciegen Pharms Inc, Sun Pharm Inds, Teva, and Wockhardt. and is included in six NDAs.
The generic ingredient in FEXOFENADINE HYDROCHLORIDE HIVES is fexofenadine hydrochloride. There are twenty-three drug master file entries for this compound. One hundred and four suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fexofenadine Hydrochloride Hives
A generic version of FEXOFENADINE HYDROCHLORIDE HIVES was approved as fexofenadine hydrochloride by TEVA on September 1st, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FEXOFENADINE HYDROCHLORIDE HIVES?
- What are the global sales for FEXOFENADINE HYDROCHLORIDE HIVES?
- What is Average Wholesale Price for FEXOFENADINE HYDROCHLORIDE HIVES?
Summary for FEXOFENADINE HYDROCHLORIDE HIVES
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 54 |
| Raw Ingredient (Bulk) Api Vendors: | 128 |
| Clinical Trials: | 79 |
| Patent Applications: | 1,698 |
| DailyMed Link: | FEXOFENADINE HYDROCHLORIDE HIVES at DailyMed |
Recent Clinical Trials for FEXOFENADINE HYDROCHLORIDE HIVES
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Bristol-Myers Squibb | Phase 1 |
| Dhaka Medical College | Phase 2/Phase 3 |
| Opella Healthcare Group SAS, a Sanofi Company | Phase 3 |
Pharmacology for FEXOFENADINE HYDROCHLORIDE HIVES
| Drug Class | Histamine-1 Receptor Antagonist |
| Mechanism of Action | Histamine H1 Receptor Antagonists |
US Patents and Regulatory Information for FEXOFENADINE HYDROCHLORIDE HIVES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Ltd | FEXOFENADINE HYDROCHLORIDE HIVES | fexofenadine hydrochloride | TABLET;ORAL | 076502-007 | Apr 12, 2011 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sun Pharm Inds | FEXOFENADINE HYDROCHLORIDE HIVES | fexofenadine hydrochloride | TABLET;ORAL | 091567-003 | Feb 6, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Rising | FEXOFENADINE HYDROCHLORIDE HIVES | fexofenadine hydrochloride | TABLET;ORAL | 077081-009 | Jul 21, 2011 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
